Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

Equity for excellence in academic institutions: a manifesto for change

Wedekind L. et al, (2021), Wellcome Open Research, 6, 142 - 142

Effect of epitope variant co-delivery on the depth of CD8 T cell responses induced by HIV-1 conserved mosaic vaccines

Wee EG. et al, (2021), Molecular Therapy - Methods & Clinical Development, 21, 741 - 753

Revealing the extent of the first wave of the COVID-19 pandemic in Kenya based on serological and PCR-test data

Ojal J. et al, (2021), Wellcome Open Research, 6, 127 - 127

Ultra-low dose immunization and multi-component vaccination strategies enhance protection against malaria in mice.

Collins KA. et al, (2021), Sci Rep, 11

Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

Ewer KJ. et al, (2021), Nature Medicine

Systems Immunology: Revealing Influenza Immunological Imprint

Tomic A. et al, (2021), Viruses, 13, 948 - 948

Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells.

Parker R. et al, (2021), Cell Rep

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

Ahern DJ. et al, (2021)

Effects of different types of written vaccination information on COVID-19 vaccine hesitancy in the UK (OCEANS-III): a single-blind, parallel-group, randomised controlled trial.

Freeman D. et al, (2021), The Lancet. Public health

Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data.

Shaw RH. et al, (2021), Lancet (London, England)

Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8+ T cell antiviral responses.

Yang H. et al, (2021), Cell Rep, 35

Re-thinking yellow fever vaccines: fighting old foes with new generation vaccines

Montalvo Zurbia-Flores G. et al, (2021), Human Vaccines & Immunotherapeutics, 1 - 9

ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets.

Marsh GA. et al, (2021), NPJ vaccines, 6

Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Barrett JR. et al, (2021), Nature Medicine

Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.

Datoo MS. et al, (2021), Lancet (London, England), 397, 1809 - 1818

Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations.

Mokaya J. et al, (2021), Journal of viral hepatitis

Seroprevalence of Antibodies to SARS-CoV-2 among Health Care Workers in Kenya.

Etyang AO. et al, (2021), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

MMR Vaccine Attitude and Uptake Research in the United Kingdom: A Critical Review

Torracinta L. et al, (2021), Vaccines, 9, 402 - 402

Recombinant protein vaccines against SARS-CoV-2.

Gilbert SC. and Lambe T., (2021), The Lancet. Infectious diseases

Improving statistical power in severe malaria genetic association studies by augmenting phenotypic precision

Watson JA. et al, (2021)

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?